<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38062">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02611011</url>
  </required_header>
  <id_info>
    <org_study_id>4005B</org_study_id>
    <nct_id>NCT02611011</nct_id>
  </id_info>
  <brief_title>Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Survey</brief_title>
  <official_title>Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Survey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gynuity Health Projects</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nationwide Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gynuity Health Projects</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if pregnant women can understand the instructions, carry out the test, and
      interpret the test results regarding the need for follow-up or treatment women will be
      recruited to complete a test instruction and comprehension assessment and a usability
      assessment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine if pregnant women can understand the instructions, carry out the test, and
      interpret the test results regarding the need for follow-up or treatment women will be
      recruited to complete a test instruction and comprehension assessment and a usability
      assessment. Study participants will be a convenience sample of women seeking prenatal
      services. Participants will first be asked to review the instructions for the Congo Red Dot
      Test and complete a short written questionnaire that assesses their comprehension of the
      test instructions. Participants will then be asked to perform the test using their own urine
      sample and to interpret the results obtained by answering a second written questionnaire.
      After the woman performs the test, a healthcare provider will use the urine sample to
      perform a second test.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>CRD Test Comprehension</measure>
    <time_frame>within 1 hour of test use</time_frame>
    <description>proportion of women who demonstrated various levels of understanding of the instructions for the CRD Test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CRD Test Usability</measure>
    <time_frame>within 1 hour of test use</time_frame>
    <description>the proportion of women able to correctly use the CRD test</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">198</enrollment>
  <condition>Preeclampsia</condition>
  <arm_group>
    <arm_group_label>Pregnant women</arm_group_label>
    <description>Pregnant women seeking prenatal services at Hospital Materno-Infantil Inguarán will take the Congo Red Dot Test individually by following the Congo Red Dot Test instructions</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Congo Red Dot Test</intervention_name>
    <description>The Congo Red Dot test is a simple test has been developed to detect unfolded or misfolded proteins in urine.</description>
    <arm_group_label>Pregnant women</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      urine samples collected
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women attending Hospital Materno-Infantil Inguarán for prenatal care will be eligible for
        the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant

          -  Eligible to consent for research

          -  Able to read Spanish well enough to read the test instructions

          -  Able to give informed consent

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Irina Buhimschi, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nationwide Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Beverly Winikoff, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gynuity Health Projects</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hillary Bracken, PhD</last_name>
    <phone>4342490286</phone>
    <email>hbracken@gynuity.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Meighan Tarnagada, MPH</last_name>
    <phone>4044337731</phone>
    <email>mtarnagada@gynuity.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Materno-Infantil Inguarán</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carmen C Sotelo, Dr</last_name>
      <email>patriciosanhueza@prodigy.net.mx</email>
    </contact>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 15, 2016</lastchanged_date>
  <firstreceived_date>November 18, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Congo Red Dot Test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
